期刊文献+

阿托伐他汀在急性冠状动脉综合征中的抗炎作用及临床应用 被引量:25

Anti-inflammatory Effect of Atorvastatin and Clinical Application in Acute Coronary Syndrome
在线阅读 下载PDF
导出
摘要 近年来研究发现,他汀类药物不仅具有降脂作用,而且在急性冠状动脉综合征中还具有抗炎作用。阿托伐他汀作为新一代他汀类新药在调节免疫抑制炎症方面具有更好的疗效,在阻止动脉硬化的发生、发展过程中,以及在急性冠状动脉综合征预防、早期治疗、后期延缓终末事件的发生中有明显的治疗效果,这种抗炎作用是独立于降脂作用之外的,其临床应用剂量国内外差异较大,应注意合理应用。 Recent studies showed that atorvastatin not only has effect decreasing lipid, but also has antiinflammatory effect in acute coronary syndrome. As a new generation of the statins, atorvastatin has the better curative effect on the regulation of immunity and inhibition of inflammation, it also has significant curative effect in inhibiting the genesis and development of atherosclerosis, preventing acute coronary syndrome, treating this disease early and postponing the advanced cases of this desease. Its anti-inflammatory effect can independent to its effect of lipid-decreasing. We should pay more attention to its rational usage because of great difference about its clinical dosage in domestic and abroad.
出处 《医学综述》 2008年第12期1888-1890,共3页 Medical Recapitulate
关键词 急性冠状动脉综合征 阿托伐他汀 抗炎作用 临床应用 Acute coronary syndrome Atorvastatin Anti-inflammatory effect Clinical application
  • 相关文献

参考文献19

二级参考文献134

  • 1李大主,Sharma Ranjit,曾秋棠,田园,冯义柏,王祥,曹林生.阿托伐他汀对不稳定型心绞痛患者树突状细胞功能的影响[J].中华内科杂志,2004,43(6):429-432. 被引量:21
  • 2刘志福,杨光,梁英,刘蕴玲.阿托伐他汀强化治疗ACS的疗效、安全性及其对纤溶系统的影响[J].山东医药,2004,44(22):40-41. 被引量:8
  • 3吴国新,阮长耿.血小板颗粒膜蛋白研究进展[J].中华血液学杂志,1994,15(3):162-164. 被引量:231
  • 4李大主,RanjitS,吴伟,周游,曾秋棠.急性冠状动脉综合征患者树突状细胞介导的热休克蛋白60特异性细胞毒作用[J].中国循环杂志,2005,20(5):340-343. 被引量:7
  • 5[1]Kinlay S, Selwyn AP, Delagrange D, et al. Biological mechanisms for the clinical success of lipid - lowering in coronary artery disease and the use of surrogate end points [ J ]. Curr Opin Lipidol, 1996,7: 389 - 397.
  • 6[2]Eugene Braunward MD, Chair Joel Kupersmith MD, Elliott M Antman MD, et al. ACC / AHA 2002 Guideline Update for Management of Patients with Unstable Angina and Non - ST - Segment Elevation Myocardial Infarction[J].J Am Coll Cardiol, 2002,40: 366 - 374.
  • 7[4]Kinlay S, Schwartz GG, Olsson AG, et al. Biological mechanism for the clinical success of lipid - lowering in coronary arthry disease and the use of surrogate endpoints [J]. Curr Opin Lipidol, 1996,7 . 389 - 397.
  • 8[5]Bybee KY, Wright RS, Kopecky SL. Effect of early statin therapy after actue coronary syndromes :a concise review of the recent data[ J ]. Cardiol Rew,2002,10(5) :301 - 305.
  • 9[6]Mosca L,Biviano A. Lipid - lowering therapies in the management of acute coronary syndromes [ J ]. Curr Cardiol Rep, 2002,4 (4): 320 - 326.
  • 10[7]Water DD. Early pharmacologic intervention and plaque stability in acute coronary syndromes [J]. Am J Cardiol, 2001,88 (8A) :30K -36K.

共引文献163

同被引文献207

引证文献25

二级引证文献170

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部